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ReplicationJC virus (JCV) encodes a small basic phosphoprotein from the late coding region called agnoprotein, which
has been shown to play important regulatory roles in the viral replication cycle. In this study, we report
that agnoprotein forms highly stable dimers and higher order oligomer complexes. This was conﬁrmed by
immunoblotting and mass spectrometry studies. These complexes are extremely resistant to strong denatur-
ing agents, including urea and SDS. Central portion of the protein, amino acids spanning from 17 to 42 is im-
portant for dimer/oligomer formation. Removal of 17 to 42 aa region from the viral background severely
affected the efﬁciency of the JCV replication. Extracts prepared from JCV-infected cells showed a double band-
ing pattern for agnoprotein in vivo. Collectively, these ﬁndings suggest that agnoprotein forms functionally
active homodimer/oligomer complexes and these may be important for its function during viral propagation
and thus for the progression of PML.rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Dimer and higher order oligomer formation of proteins is com-
mon, and is frequently a necessary phenomenon for biological sys-
tems. Subunit interactions are essential processes for regulation of
the functions of many proteins including enzymes, ion channels, re-
ceptors and transcription factors (Marianayagam et al., 2004).
Dimer/oligomer formation can also help to minimize the genome
size of the organisms by allowing multiple combinations of active
protein molecules. On the contrary, such formations may have harm-
ful consequences for a biological system when non-native oligomers
associated with pathogenic states are generated. For example,
β-amyloid deposition in the brains of affected individuals results in
Alzheimer's disease. This protein forms ﬁbrillar structures through
the self-association of the monomers (Serpell et al., 1997; Sunde
and Blake, 1997; Sunde et al., 1997).
There are many examples of the self-association and oligomeriza-
tion of viral proteins. Examples include polyomavirus large T antigen,
(LT-Ag) and human deﬁciency virus 1 (HIV-1) small proteins, Rev and
vpr. LT-Ag binds to its target sequences as a double hexamer in the
origin of replication and initiates the viral DNA replication (Aubornet al., 1988; Lynch and Frisque, 1990; Simmons et al., 1990). Rev, a
small HIV-1 protein, is involved in the transport of incomplete spliced
RNA molecules from nucleus to cytoplasm. This protein binds to Rev
response elements present in the intron region of the viral transcripts
and was found to function as both stable dimers and oligomers as evi-
denced by 3D structural studies (Daugherty et al., 2008, 2010a,
2010b; DiMattia et al., 2010). Like Rev, Vpr also forms stable dimers,
arrests cells at G2/M phase transition and induces apoptosis (Bolton
and Lenardo, 2007; Cui et al., 2006; Fritz et al., 2008, 2010; Godet
et al., 2010; Iordanskiy et al., 2004; Poon et al., 2007). Vpr 3D struc-
ture has been determined by NMR, showing that the carboxy-
terminal helix is responsible for its dimer formation (Bourbigot et
al., 2005). An Ebola virus-speciﬁc transcription factor, VP30 was also
found to form homodimers. A region within this protein spanning
amino acid residues 94–112 is essential for oligomerization, where a
cluster of four leucine residues was shown to have a critical impor-
tance. Mutation of only one of these leucine residues resulted in a
molecule that no longer forms oligomers and therefore supports
EBOV-speciﬁc transcription (Hartlieb et al., 2003). Some viral pro-
teins undergo nucleic acid-induced polymerization process in a se-
quence speciﬁc manner. One example of those is the Borna disease
virus (BDV) nucleoprotein which requires the presence of 5′-speciﬁc
BDV RNA for its oligomerization process (Hock et al., 2010).
JC virus (JCV), a member of the polyomaviridae family of viruses is
known to be the etiologic agent of fatal disease, progressive
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Major et al., 1992). The viral genome encodes several regulatory pro-
teins, including large T antigen (LT-Ag), small t antigen (Sm t-Ag)
T′165, T′136, T′135 and agnoprotein (Bollag et al., 2006, 2010; Khalili
et al., 2005, 2008; Major et al., 1992; Safak et al., 2001). Agnoprotein
is a small basic protein, expressed by all three JCV, BK virus (BKV) and
simian virus 40 (SV40) polyomaviruses. Its expression during the
viral lytic cycle has been demonstrated by biochemical and immuno-
cytochemical methods in infected cells (Gilbert et al., 1981; Rinaldo
et al., 1998; Safak et al., 2002) and in tissue sections (Okada et al.,
2002). It is a predominantly cytoplasmic protein localized to the peri-
nuclear region of infected cells, however, a small fraction of it was
also found to be localized to the nucleus. This is supported by a recent
report by Unterstab et al., where it was found that agnoprotein be-
comes nuclear when both amino acids 25 (Ala) and 39 (Phe) are mu-
tated to aspartic acid (Asp) and glutamic acid (Glu) respectively
(Unterstab et al., 2010). Amino acid sequence alignment of the agno-
proteins for JCV, BKV and SV40 shows about 70% sequence identity
among these functionally related proteins (Khalili et al., 2005; Safak
et al., 2001). While the amino-terminal and central regions of each
agnoprotein exhibit considerable sequence identity with one another,
the sequences toward the carboxy-terminal region are more divergent.
It has been recently shown that amino terminus of agnoprotein is
targeted for phosphorylation by a well-characterized protein kinase,
protein kinase C (PKC). This modiﬁcation plays a signiﬁcant role in
the function of this protein during the viral replication cycle of BK
virus and JC virus (Johannessen et al., 2008; Sariyer et al., 2006).
SV40 agnoprotein was also previously reported to be phosphorylated
but no function was assigned to it (Nomura et al., 1983). Agnoprotein
has also been previously found to functionally interact with viral and
cellular proteins, including LT-Ag (Safak et al., 2001) and Sm t-Ag
(Sariyer et al., 2008), Y-box binding protein, Yb-1 (Safak et al.,
2002), p53 (Darbinyan et al., 2002) and HP1α (Suzuki et al., 2005).
Mutational analysis of agnoprotein from the closely related virus
SV40 suggested that it may have effects on various aspects of the
viral lytic cycle including transcription, translation, virion production
and maturation of the viral particles (Alwine, 1982; Haggerty et al.,
1989; Hay et al., 1982; Hou-Jong et al., 1987; Margolskee and
Nathans, 1983; Ng et al., 1985a, 1985b).
Based on amino acid sequence, the predicted molecular weight of
JCV agnoprotein is ~8.00 kDa. However, this protein has been previ-
ously detected as two discrete bands in extracts prepared from both
transfected and infected cells (Del Valle et al., 2002; Merabova et al.,123 
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Fig. 1. Expression of agnoprotein as GST and MBP fusion protein. (A) GST alone (5 μg) and G
separated on a 10% SDS-polyacrylamide gel and analyzed by coomassie staining. (B) MBP alo
FF resin, separated on a 10% SDS-polyacrylamide gel and analyzed by coomassie staining.2008). These ﬁndings are also consistent with recent observations
by Suzuki et al.(2010), who demonstrated the homodimer and homo-
oligomer formation of agnoprotein by intermolecular ﬂuorescence
resonance energy transfer (FRET) analysis and chemical crosslinking
studies. It was also previously observed that bacterially produced
GST-fusion protein of agno was found to induce multiple higher mo-
lecular weight protein complexes (Safak et al., 2001). Those com-
plexes were initially thought to be bacterial proteins that strongly
interact and co-purify with agnoprotein during the afﬁnity puriﬁca-
tion process (Safak et al., 2001). Previously, it was not clear that
they result from the dimer/oligomer formation property of agnopro-
tein itself. In this report, we have shown that bacterially produced
MBP and GST fusion agnoproteins form highly stable homodimers
and oligomers in vitro, mapped the dimerization domain of agnopro-
tein to amino acids 17–42 and investigated the functional conse-
quences of the deletion of the dimerization domain from the viral
background, where deletion of this domain severely affected the rep-
lication cycle of JCV. Finally, analysis of agnoprotein, expressed in
infected cells, showed two discrete bands on immunoblots suggesting
that agnoprotein may also form dimers and perhaps oligomers in vivo
and functions accordingly during the JCV infection cycle.
Results
Detection of agnoprotein-induced high molecular weight complexes in
afﬁnity puriﬁed fusion protein fractions
Our previous analysis of GST-agno fusion protein by SDS-
polyacrylamide gel consistently revealed the presence of additional
agnoprotein-induced higher molecular weight complexes (Safak
et al., 2001; Sariyer et al., 2006). These complexes were originally pre-
sumed to be bacterial proteins that strongly interact and thereby co-
purify with agnoprotein during afﬁnity puriﬁcation process (Safak
et al., 2001; Sariyer et al., 2006). In this report, we sought to further
investigate the nature of these complexes, by determining whether
complex formation only occurs when it is fused to GST (glutathi-
one-S-transferase). To address this question, agnoprotein was fused
to a maltose binding protein (MBP), then expressed in Escherichia
coli and puriﬁed by afﬁnity chromatography. As shown in Figs. 1A
and B, the expected size of monomeric GST-Agno is near 32 kDa and
that of MBP-Agno is 51 kDa. However, in both cases, additional
bands were observed in the respective lanes, running at signiﬁcantly
higher levels than the expected sizes of each agno fusion protein (GSTMB
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53A.S. Saribas et al. / Virology 420 (2011) 51–65and MBP). This eliminates the possibility that the observed phenom-
enon is a fusion protein-speciﬁc case, but rather occurs regardless of
the type of the backbone of the fusion protein. It was also our experi-
ence working with MBP-Agnoprotein construct that it was found to
be expressed in higher amounts in E. coli than GST-Agno and readily
eluted from the afﬁnity resin compared to GST-Agno. Due to these
reasons, MBP-Agno construct was chosen for further protein charac-
terization studies.
Detection of high molecular weight complexes by anti-agno antibody
Next, the identity of the proteins participating in these complexes
was investigated to determine if these proteins are in fact bacterial pro-
teins that co-purify with agnoprotein during afﬁnity puriﬁcation or, al-
ternatively, whether agnoprotein itself can form stable homodimersA
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Fig. 2. Analysis of agnoprotein-associated high molecular weight proteins by immunoblottin
an 8% SDS-polyacrylamide gel and analyzed by coomassie staining. (B) Immunoblot analysi
MBP-Agno (100 ng) were separated on an 8% SDS-polyacrylamide gel, transferred onto nitro
and detected with ECL. (C) Intact MBP-Agno (5 μg) (lane 1) and cleaved form by Factor Xa a
analyzed by coomassie staining. A bracket points to the cleavage products of MBP-Agno. (D).
methods, separated on a 15% SDS-polyacrylamide gel and analyzed byWestern blotting usin
JCV Agno, MBP-BKV Agno and MBP-SV40 Agno (5 μg each) were separated on an 8% SDS-po
fusion protein of JCV, BKV and SV40 agnoproteins. Afﬁnity puriﬁed MBP alone (5 μg), MBP-JC
on an 8% SDS-polyacrylamide gel, transferred onto nitrocellulose membrane, probed with aand oligomers, resulting in this pattern of higher molecular weight
bands on SDS-polyacrylamide gel. To distinguish between these two
possibilities, afﬁnity puriﬁed MBP alone and MBP-Agno were separated
on a 10% SDS-polyacrylamide gel (Fig. 2A), then transferred on a nitro-
cellulose membrane and probed with an anti-agnoprotein antibody
(Fig. 2B). As expected, MBP-Agno (monomer) was detected on the
membrane at about 51 kDa (see MALDI-TOF analysis, Supplement 2).
However, the anti-agnoprotein antibody also detected all of the higher
molecular weight complexes that were observed on a SDS-
polyacrylamide gel, while no higher molecular weight bands were
detected in the lane that contained MBP alone (Fig. 2B, lane 1). These
ﬁndings support a case that the higher molecular weight complexes re-
sult from a stable homodimer and oligomer formation property of agno-
protein itself. Next, the identity of each high molecular weight complex
was determined by mass spectrometry analysis (see Supplement 1,B
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54 A.S. Saribas et al. / Virology 420 (2011) 51–65Ducret et al., 1998). Results showed that these complexes mainly con-
sists of MBP and agnoprotein with little impurities, strongly suggesting
that high molecular weight bands result from the homodimer and olig-
omer formation property of agnoprotein, but did not exclude a possibil-
ity that a bacterial protein or proteins could be a part of these complexes.
To exclude this possibility, we investigated the content of agnoprotein
dimers with a highly sensitive MALDI-TOF analysis (see Supplement
2). It turned out that agnoprotein dimer complexes do not contain any
other bacterial protein, clearly conﬁrming the case that stable dimer for-
mation results from the intrinsic homodimer formation property of
agnoprotein itself.Factor Xa cleavage products were detected by anti-agno antibody
running as multiple bands
In order to investigate whether MBP protein alone contributes to
dimer and oligomer formation of MBP-Agno, agnoprotein was
cleaved from MBP by using Factor Xa and the resulting productsFig. 3. Mapping of the region of agnoprotein responsible for dimer and oligomer formation.
acids (17–42) was deleted from the viral background (Agno-Δ17–42). (B) Predicted three
2010). (C) FL agnoprotein and its deletion mutants (aa 1–42, 1–16, 17–71, and 43–71) were
alyzed by coomassie staining. (D) Map of agnoprotein depicting the regions critical for dim
formation respectively.were analyzed by a SDS-polyacrylamide gel (Fig. 2C) followed by
Western blotting (Fig. 2D). The majority of the higher molecular
weight complexes disappeared upon cleavage by Factor Xa, although
a small amount of uncleaved products remained intact, likely due
to incomplete cleavage reaction (Fig. 2C, lane 2). Detection of the
cleavage products by anti-agnoprotein antibody as multiple bands
on a Western blot further conﬁrmed that agnoprotein itself is respon-
sible for such complexes but not MBP alone (Fig. 2D). The multiple
banding patterns of the cleaved products of agnoprotein also support
the conclusion that agnoprotein not only forms homodimers and olig-
omers, but that those complexes are highly stable under denaturing
conditions.
Since JCV, BKV and SV40 agnoproteins show high degree of ho-
mology (N70%) with one another, we reasoned that BKV and SV40
agnoproteins also form dimer/oligomers. SDS-polyacrylamide gel
analysis of MBP-fusion protein of BKV and SV40 agnoproteins fol-
lowed by coomassie staining clearly showed that both proteins also
form similar stable dimer/oligomers (Fig. 2E) and immunoblotting
studies conﬁrmed these ﬁndings (Fig. 2F).
Mapping of the agnoprotein region(s) responsible for dimer and oligo-
mer formation
In order to map the region(s) of agnoprotein responsible for dimer
and oligomer formation, different deletion mutants of agnoprotein
were expressed in E. coli as MBP-Agno fusion and then afﬁnity puri-
ﬁed. The ability of dimer/oligomer formation of these mutants was
analyzed by SDS-polyacrylamide gel followed by coomassie staining
(Fig. 3C). As expected, FL agnoprotein forms a stable dimer and olig-
omers (Fig. 3C, lane 3). Deletion of a 29 aa region from the carboxy-
terminus (1–42 construct) and a 16 aa region from the amino-
terminus (17–71 construct) of agnoprotein did not have a noticeable
effect on the ability to form higher molecular weight complexes
(lanes 4 and 5, respectively). However, deletion of a 55 aa region
from the carboxy-terminus (1–16 construct) and a 42 aa region
from the amino-terminus (43–71 construct) abrogated dimer/oligo-
mer formation ability of agnoprotein (Fig. 3C, lanes 6 and 7 respec-
tively). From this data, it was deduced that the central portion of
agnoprotein, encompassing the aa 17–42 region, is critical for the for-
mation of dimers and oligomers. According to a computer-generated
protein structural model, agnoprotein adopts an α-helical structure
within 17–42 amino acid region (Fig. 3B). Future studies are required
to further delineate the amino acids responsible for dimer/oligomer
formation of agnoprotein. The dimer/oligomer formation ability of
FL agnoprotein and the various truncation mutants are summarized
in Fig. 3D. The FL of the primary sequences (WT agno) and its truncat-
ed version (Agno Δ17–42) are shown in Fig. 3A.
Dimers and oligomers of agnoprotein are resistant to strong denaturing
conditions
One of the interesting characteristics of the dimers and oligomers
of agnoprotein is being resistant to denaturing agents under normal
SDS-polyacrylamide gel conditions. To test their ability to resist
even stronger denaturing agents, these complexes were examined
in the presence of high concentration of urea and SDS. To this end,
5 μg of MBP-Agno was treated with 8 M urea (ﬁnal concentration)
for different times at room temperature. SDS-sample buffer was(A) Primary sequence of agnoprotein (Agno-WT). Highlighted region spanning amino
dimensional structure of agnoprotein was generated by I-Tasser program (Roy et al.,
fused to MBP, expressed in E. coli, separated on an 8% SDS-polyacrylamide gel and an-
er/oligomer formation. “+” and “−” indicate presence and absence of dimer/oligomer
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56 A.S. Saribas et al. / Virology 420 (2011) 51–65then added to the protein, heated at 95 °C for increasing times from 5
to 120 min, followed by separation on a 10% SDS-polyacrylamide gel
and coomassie staining. Unexpectedly, the treatment with 8 M urea
did not have a signiﬁcant effect on the integrity of homodimers and
oligomers (Fig. 4A, lanes 4, 6, 8 and 10). The behavior of the homodi-
mers and oligomers of agnoprotein was also analyzed in the presence
of high concentration of SDS, ranging from 4% to 20%. Even the addi-
tion of increasing levels of SDS had only a minor effect on the integri-
ty of the homodimers and oligomers of agnoprotein, even at the
highest levels of SDS tested (Figs. 4B and C).123 
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3: No prior SDS treatment. (C) Protein bands corresponding dimers and oligomers were qu
ative to the control sample without pre-SDS treatment.Prolonged heat treatment shows a considerable effect on the destabilization
of agnoprotein dimers and oligomers
The extreme stability of agnoprotein dimers and oligomers under
different strong denaturing conditions could be either the result of co-
valent bond formation or strong non-covalent interactions, such as
salt bridges and hydrophobic interactions, between the agnoprotein
monomers. Prolonged heat treatment of the protein samples would
test these two possibilities since non-covalent interactions will be less
resistant to thermal denaturation. MBP alone or MBP-AgnoproteinMBP 
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mple buffer. Samples were then heated at 95 °C for 5 min, separated on an 8% SDS-
(10 μg) were resuspended in 1×SDS Laemmli sample buffer after pretreatment of in-
DS-polyacrylamide gel and analyzed by coomassie staining. Lane 2: MBP control. Lane
antiﬁed by gel densitometry using ImageJ program. Percent values were calculated rel-
57A.S. Saribas et al. / Virology 420 (2011) 51–65sampleswere exposed to prolonged heat treatment ranging from5 min
to 60 min at 95 °C. Following heat treatment, the samples were divided
into two portions, one portion separated by a SDS-polyacrylamide gel,
while the other portion was analyzed by Western blotting using an
anti-agno polyclonal antibody. Approximately 60% of the homodimers
and 85% of the homo-oligomers were destroyed upon 1 h heat treat-
ment and consequently MBP-Agno monomer band intensity increased
(Figs. 5A–C), suggesting that the high resistance of the dimers and olig-
omers of agnoprotein against strong denaturing agents is not the result
of covalent cross-linking, but likely from numerous strong ionic and hy-
drophobic attractions between the monomers.
The level of dimer and oligomer formation of agnoprotein increases in a
time- and temperature-dependent manner
During the initial characterization of agnoprotein dimers and
oligomers, it was observed that the levels of dimer/oligomers1 4 3 2 
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et al., 2006) (B). (C) Densitometry analysis was performed using Image J software to determ
were plotted against corresponding temperatures.signiﬁcantly increased over time, seen upon storages at temperatures
above 0 °C. It was reasoned that temperatures above the freezing
point may have a positive effect on the rate of dimer and oligomer
formation of agnoprotein in vitro. To investigate the effect of temper-
ature, afﬁnity column puriﬁed fresh protein samples were stored at
−30 °C, 4 °C, 25 °C and 37 °C for 24 h and then were analyzed by a
SDS-polyacrylamide gel. The level of dimer and oligomer formation
increased in a temperature-dependent manner, with higher levels
seen in samples kept at 37 °C for 24 h (Fig. 6A, lane 5) compared to
those stored at −30 °C (Fig. 6A, lane 2). These ﬁndings conﬁrm the
effect of temperature on dimer and oligomer formation of agnopro-
tein. It was also observed that the level of the intensity of a band, in-
dicated by an arrow, remained virtually unchanged under the same
conditions, even though this band also contained agnoprotein by
mass spectrometry analysis. This band likely resulted from a cleavage
product of MBP-Agno causing a differential fractionation of the pro-
tein complex.Monomer 
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points to a cleavage product of MBP-Agno. (B) The signal levels on the bands corre-
sponding to the dimers and oligomers were densitometrically determined using Ima-
geJ software and plotted against corresponding temperatures.
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chromatography
Amylose afﬁnity column puriﬁed MBP-Agnoprotein was further
puriﬁed by ion-exchange chromatography, followed by gel ﬁltration
to characterize the behavior of the monomers, dimers and oligomers
in solution. As shown in Fig. 7A, any free MBP can easily be separated
from the rest of MBP-Agnoprotein (Fig. 7A, fractions 1–6). However,
the agnoprotein complexes (monomers, dimers and oligomers)
were not separated from each other on an ion-exchange column
(fractions 5–13). Each fraction contained all forms of agnoprotein
(monomers, dimers, and oligomers). This suggests that either each
form of agnoprotein exhibits a similar afﬁnity to the column or they
remain as a single complex in the chromatography solution that
was used. To further investigate these questions, fractions 7 through
14 were pooled and run through a gel ﬁltration column (Fig. 7B). It
turned out that all of the agnoprotein complexes were found to co-
elute from this column, even though each complex has a different
size by SDS-polyacrylamide gel analysis, suggesting that some com-
plexes tightly and some others loosely bound one other under chro-
matography buffer conditions.
Detection of agnoprotein as two distinct bands in extracts from infected
cells
The ﬁnal issue to be resolved is whether agnoprotein can also
forms stable dimer/oligomer structures in infected cells, and perhaps
these higher order structures may have functional roles in vivo. To ad-
dress this question, SVG-A cells, derived from primary human glialcells, (Major et al., 1985) were infected and whole cell extracts pre-
pared at 15th day of post infection were analyzed either by direct
Western blotting or by immunoprecipitation (IP):Western using an
anti-agnoprotein antibody. As seen in Fig. 8, both in direct Western
(lanes 1 and 2) and in IP:Western cases (lanes 5 and 6), agnoprotein
was detected as two distinct bands, with the upper band as the most
prominent one. The presence of multiple forms of agnoprotein in
these infected cells supports the ﬁndings from in vitro studies, and
is also consistent with previous reports in the literature by Del Valle
et al.(2002) and Merabova et al.(2008). Each reported the detection
of agnoprotein byWestern blotting as two distinct bands under dena-
turing conditions, however, no explanation was provided for their
ﬁndings. More recently, Suzuki et al., also reported the dimerization
and oligomerization of agnoprotein in transfection assays by ﬂuores-
cence resonance energy transfer (FRET) technique and cross-linking
respectively (Suzuki et al., 2010). The ﬁndings in this current study,
combined with those from previous studies show that agnoprotein
forms, and perhaps even functions, as a dimer or higher order oligo-
mer during viral replication cycle.
Deletion of amino acids from 17 to 42 region of agnoprotein severely af-
fects the viral replication cycle
Mapping of the dimerization/oligomerization domain of agnopro-
tein demonstrated that, in the absence of amino acids 17–42 region,
the ability of dimer/oligomer formation of agnoprotein was abol-
ished. We next wanted to test the functional consequences of the de-
letion of this region on the level of the JCV protein expression and
replication. JCV Mad-1 genome lacking the amino acids 17–42 region
of agnoprotein and JCVWTwas transfected into SVG-A cells separate-
ly and nuclear extracts were prepared at 5th and 15th days of post-
transfection and analyzed for the expression level of VP1 by
Western blotting. As shown in Fig. 9A, JCV capsid protein VP1 is read-
ily detectable at the 5th day of posttransfection in extracts prepared
from the cells transfected with either WT (lane 4) or mutant viral ge-
nome (lane 2). Even the level of VP1 expression for mutant virus was
higher than WT at 5th day posttransfection. Surprisingly, while the
level of expression of VP1 increased signiﬁcantly in the extracts pre-
pared at 15th day time point, as expected, from the cells transfected
with WT genome, the mutant virus was not able to sustain its replica-
tion cycle until 15th day posttransfection. The level of VP1 expression
was undetectable at this time point. In parallel, the ability of the rep-
lication of the mutant virus was also analyzed by Dpn I assay. This
assay detects only the newly replicated viral DNA while digesting
away the transfected DNA (input) by Southern blot analysis as de-
scribed under Materials and methods. Using this method, one can dis-
tinguish the newly replicated DNA from the input DNA (transfected
into the cells). Consistent with our ﬁndings from protein expression
studies in Fig. 9A, the mutant virus was found to replicate as efﬁcient-
ly asWT by 5th day posttransfection (compare lane 2 to lane 4). How-
ever, while the level of replication of WT signiﬁcantly increased at
15 day posttransfection, as expected, that of mutant dropped to the
undetectable levels (compare lanes 3 to 5). Taken together, these
ﬁndings suggest that deletion of the dimerization/oligomerization
domain of agnoprotein severely affects both the viral protein expres-
sion, VP1, and replication in long-term infection cycles of JCV.
Analysis of the virions released from the cells infected with Mad-1 agno
(Δ17–42) mutant
The inability of agnoprotein deletion mutant to sustain viral repli-
cation cycle suggested a possibility that this mutant virus was either
defective in release of the infectious viral particles or that the released
particles were deﬁcient in DNA content. To distinguish between these
possibilities, a viral release assay was performed, where the released
viral particles were immunoprecipitated from the culture media and
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Fig. 7. Puriﬁcation of MBP-Agno by ion-exchange and gel exclusion chromatography. (A) After amylose FF afﬁnity puriﬁcation, the fractions containing MBP-Agno was pooled and
dialyzed as described in Materials and methods and loaded onto a Q Sepharose anion exchange column (25 mL). The column washed with a buffer A (see Materials and methods)
and proteins were eluted using a linear NaCl gradient (50–1000 mM). The fractions were collected and protein samples were analyzed on a 4–20% SDS-polyacrylamide gel followed
by coomassie blue staining. (B) Puriﬁcation of agnoprotein by gel ﬁltration column. After Q Sepharose puriﬁcation step fractions containing MBP-Agno were pooled and applied to a
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The culture media was collected from the cells transfected either with
WT or mutant at different time points and viral particles were sub-
jected to immunoprecipitation using an anti-VP1 antibody. The sam-
ples were then split into two equal portions. One portion was
analyzed byWestern blotting using anti-VP1 antibody. The other por-
tion was analyzed by Southern blotting for detection of encapsidated
viral DNA. As shown in Fig. 9C, VP1 was readily detectable for WT atevery time point taken posttransfection (lanes 3 and 4) by Western
blotting. We also observed comparable levels of virion release for
the mutant virus at 5th day posttransfection (lanes 1). However, the
observed signal declined to undetectable levels 15th day data point
for the mutant virus compared to WT (lanes 2 and 4 respectively).
These results demonstrated that the mutant virus was capable of re-
leasing the viral particles at least as efﬁciently as WT. In light of
these ﬁndings, we then reasoned that perhaps the released viral
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successfully propagate. To investigate this possibility, we analyzed
the viral DNA content of the other half of the immunoprecipitated
samples by Southern blotting. As demonstrated in Fig. 9D, we
detected, as expected, a relatively strong signal for encapsidated WT
viral DNA, isolated at 5th day posttransfection (lane 3) and the inten-
sity of the signal gradually increased for the later time point (lane 4).
In contrast, we detected a relatively weak signal for the mutant virus
at 5th day posttransfection and did not observe a detectable level of
signal for the 15th day time point, which strongly supports the hy-
pothesis that the viral particles, are efﬁciently released from the
cells transfected with the mutant virus but were mostly deﬁcient in
DNA content. It is conceivable that this results in a defective propaga-
tion cycle of the mutant virus at the subsequent rounds of infection
cycles. This ﬁnding suggests that agnoprotein may be involved in
viral encapsidation process and dimerization/oligomerization proper-
ty of agnoprotein perhaps plays a critical role in this and other pro-
cesses that agnoprotein associated with during the viral replication
cycle.
Discussion
Evidence has been presented to show that agnoprotein forms highly
stable dimers and oligomers when it is fused to GST and MBP and
expressed in E. coli. More signiﬁcantly, analysis of agnoprotein in cell ex-
tracts prepared from the infected cells also showed distinct bands indi-
cating that agnoprotein may form and function as dimer/oligomers
during viral infection cycle in vivo, correlating with the previously pub-
lished data where homodimer formation of agnoprotein was demon-
strated by intermolecular ﬂuorescence resonance energy transfer
(FRET) analysis as well as high order oligomers by biochemical cross
linking (Suzuki et al., 2010). In addition, the agnoprotein region which
is responsible for the stable dimerization/oligomerization was found
to encompass one of the predicted helical domains of the protein,
amino acids spanning 17–42. Deletion of this region from the viral back-
ground resulted in a phenotype that is unable to sustain viral replicationcycle, highlighting the importance of the dimerization domain of
agnoprotein in viral replication cycle. Our current studies in this report
clearly show the importance of the roughly mapped dimer/oligomer
formation domain of agnoprotein for its function, however it does not
tell usmuch about the exact mechanism(s) throughwhich agnoprotein
fulﬁlls its functions. Furthermutational analysis of the region is required
to gain insight into such a mechanism(s). It should, however, be men-
tioned here that previously published mapping studies almost always
pointed this dimer/oligomer formation domain of the protein as the
“protein–protein interaction domain” with other proteins, including
LT-Ag, Sm t-Ag, YB-1, p53 (Darbinyan et al., 2002; Safak et al., 2001,
2002; Sariyer et al., 2008). Collectively, it appears that this region
not only plays a role in forming dimers/oligomers but also mediates in-
teraction with other proteins. In addition, N-terminus of agnoprotein,
aa 1–18, was shown to interact with heterochromatin protein 1 (HP1)
(Okada et al., 2005).
At the beginning of these studies, it was initially assumed that the
high molecular weight complexes that had been observed resulted
from bacterial proteins that strongly interact and co-purify with agno-
protein. Alternatively, these higher molecular weight proteins may
have been produced by read-through of the stop codon. However, the
latter possibility was eliminated by demonstrating that the addition
of three consecutive stop codons at the end of the agnogene did not
prevent the formation of these protein complexes (data not shown).
In addition, detection of high molecular weight complexes with an an-
tibody, speciﬁc for agnoprotein and further analysis of these complexes
by LC–Mass Spectrometry (see Supplement 1) and MALDI-TOF spec-
trometry (see Supplement 2) conﬁrmed that higher molecular weight
complexes are generated by the ability of agnoprotein to form stable
dimer and oligomers. Particularly MALDI-TOF spectrometry analysis
of the puriﬁed MBP-Agno clearly demonstrated that no bacterial pro-
tein is present in the agnoprotein dimer complexes (see Supplement
2), which also eliminates the possibility that dimer formation is medi-
ated by a bacterial protein.
One of the interesting characteristics of these complexes is their sta-
bility in the presence of a variety of denaturing agents, including high
concentration of SDS and 8 M urea; conditions that would completely
denature most proteins. Only prolonged heat treatment at 95 °C had
a signiﬁcant effect on the integrity of these complexes, suggesting
that these assemblies are not formed by covalent bonds between the
monomers, but are most likely stabilized by a network of salt bridges
and/or hydrophobic interactions. Another interesting observation was
that the level of dimers and oligomers increased in both a time-
dependent and a temperature-dependent manner. Mapping studies
showed that the amino acids in the central core region appear to be
critical for dimer/oligomer formation. Three dimensional structure pre-
diction studies using the I-Tasser program (Roy et al., 2010) indicated
that the majority of the sequences of dimer/oligomer formation do-
main of agnoprotein most likely participate in formation of an α-
helical structure (Fig. 3B). Based on this computer generated structure,
the agnoprotein appears to possess an isoleucine-, phenylalanine- and
leucine-rich domain spanning amino acids 28–37 in this amphipathic
helix (Fig. 3A). The amphipathic nature of the α-helical region of agno-
protein was predicted by different computer-aided prediction studies
(http://heliquest.ipmc.cnrs.fr). In addition, in a recent study by Unter-
stab et al., it was reported that a roughly corresponding region from
BKV agnoprotein also exhibits an amphipathic nature (Unterstab et
al., 2010). Prediction studies also suggest that this region contains a nu-
clear export-like signal (NES-like) similar to those characterized for
HIV Rev protein (Fig. 3A). It is likely that these isoleucine- and
leucine-rich sequences present within the dimerization play critical
roles for the formation of stable dimer and oligomers.
In literature, a number of viral and eukaryotic proteins that form
SDS-resistant dimers or oligomers have also been reported. NOS
(nitric oxide synthetase) was, for example, shown to form highly sta-
ble dimers in cells that are resistant to heat and denaturing reagents
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this enzyme is a stable dimer. Several small regulatory proteins of
HIV, including vpr, Rev, Nef, vif, and tat were also reported to form
stable dimers and oligomers (Cullen, 1998a; Frankel et al., 1988a,
1988b; Kwak et al.; Yang et al., 2001; Zhao et al., 1994). Vpr forms
SDS-resistant dimers and oligomers when expressed in E. coli and
mammalian cells and dimer structure has been determined indicatingthat leu-like zipper interaction between two helixes (Bourbigot et al.,
2005; Fritz et al., 2008; Venkatachari et al., 2010; Zhao et al., 1994).
This protein is a multifunctional protein involved in different steps
of viral infection cycle, including increased transcription from the
long terminal repeats, enhances viral replication, inducing G2 cell
cycle arrest, regulating apoptosis and facilitating the entry of the
HIV pre-integration complex through the nuclear pore (Bourbigot
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1994). One of the implications that Vpr dimerization is important
for its function was provided by Fritz et al.(2010) who showed that
vpr oligomerization is crucial for HIV gag protein recognition and
the accumulation of gag at the plasma membrane (Fritz et al.,
2010). Another HIV regulatory protein Rev also forms stable dimers
and higher order oligomers evidenced by 3D structure determination.
Rev is a 116 amino acid protein that binds to the ~350 nt Rev re-
sponse element (RRE) RNA found in the introns of partially spliced
and unspliced HIV RNA, and its role is to direct HIV RNA to the cyto-
plasm. The transported RNA molecules are then either translated
into the viral proteins or are packaged as genomic RNA into the vi-
rions (Cullen, 1998a, 1998b, 2003a, 2003b; Pollard and Malim,
1998). In order to export its bound RNA, oligomeric form of Rev
binds to the human nuclear export receptor, CRM1, forming a ternary
complex stabilized by GTP-bound Ran (Cullen, 2003b; Fornerod et al.,
1997) and upon unloading its cargo, Rev shuttles back into the
nucleus. Ebola virus transcription factor VP30 was also shown to
function as a homodimer during the viral transcription. Speciﬁc mu-
tations within the dimerization region abrogated the VP30-
dependent transcription (Hartlieb et al., 2003). In JCV case, it is possi-
ble that agnoprotein may also bind to JCV-speciﬁc viral transcripts
and transport them to the translation centers in cytoplasm. In such
a scenario, the dimeric and oligomeric structures of agnoprotein
would be crucial for their binding to the viral transcripts and trans-
porting them to cytoplasm for translation.
The study of the functional properties of dimer/oligomer forma-
tion of agnoprotein is important for the understanding of its role in
JCV replication cycle. These studies will help to establish the signiﬁ-
cance of this protein for JCV life cycle. We had previously reported
that this protein is a target for phosphorylation by protein kinase C,
where Ser7, Ser11 and Thr21 were shown to be phosphorylated by
PKC. Single or combinatorial mutations at these sites converted JCV
in an essentially nonfunctional virus after the ﬁrst round of replica-
tion cycle (Sariyer et al., 2006). Similar work by Johannessen et al.,
demonstrated the functional importance of the phosphorylated
forms of agnoprotein for BKV replication cycle (Johannessen et al.,
2008). Analysis of a deletion mutant of BKV agnoprotein by Myhre
et al., also showed that BKV has a restricted life cycle in the absence
of agnoprotein, but viral function can be rescued when native agno-
protein is provided in trans (Myhre et al., 2010). In this paper, we
also attempted to further characterize the functional consequences
of the deletion of the agnoprotein dimer formation domain from the
viral background (Figs. 9A and B). Close examination of the levels of
the viral protein expression and viral DNA replication at different
time points after infections showed that in the absence of amino
acids spanning 17–42, mutant virus cannot sustain its replication
cycle in SVG-A cells. Although the level of viral protein expression
VP1 and that of replication are readily comparable between WT and
mutant at 5th day posttransfection, these levels decreased to the
undetectable levels at 15th day time point for the mutant virus
(Figs. 9A and B). These ﬁndings suggest that the 17–42 amino acid
region, which is involved in agnoprotein dimerization and oligomer-
ization, plays an essential role in the function of this protein during
the viral replication cycle. It should be noted here that it is difﬁcult
to detect the expression of the mutant agnoprotein in extracts pre-
pared from transfected/infected cells by Western. It appears that
this mutant protein after removal of the amino acids 17–42 becomes
unstable and degrades rapidly in vivo. Bacterial expression studies
with the mutant protein MBP-Agno (Δ17–42) also demonstrated
that it degrades quickly as soon as bacterial cells are lysed for protein
puriﬁcation, supporting our ﬁndings from transfection/infection stud-
ies (data not shown). Another interesting point is that although SVG-
A cells constitutively express SV40 large T antigen, which was previ-
ously shown to cross-regulate the replication of JCV (Lynch et al.,
1994), expression of LT-Ag alone is not sufﬁcient to maintainproductive viral replication cycle in the absence of WT agnoprotein.
This observation is consistent with our recent ﬁndings, where it was
observed that in the absence of agnoprotein, neither JCV nor SV40
can replicate as efﬁciently as WT (Sariyer et al., 2011).
JCV has a relatively long replication cycle. It takes 6–7 days to com-
plete its ﬁrst cycle although viral release can occur before the comple-
tion of the infection cycle in SVG-A cells. Infection cycle for SV40,
however, takes 1–2 days (Sariyer et al., 2011). Since the mutant virus
failed to sustain its replication cycle during the second round of propa-
gation, we reasoned that the mutant virus was defective in the process
of viral release from the infected cells. To address this question, a viral
release assay was employed (Figs. 9C and D) (Sariyer et al., 2006). It
was found that mutant viral particles were efﬁciently released from
the infected cells compared toWT, evidenced by detection of compara-
ble level of VP1 in the supernatant of the cells infected with either WT
or mutant (Fig. 9C). We then investigated whether the releasedmutant
viral particles were in fact deﬁcient in viral DNA content and therefore
defective in propagation. Analysis of such particles by Southern blot-
ting showed that indeed the released virions are deﬁcient in DNA con-
tent compared to WT. This, in part, explains why the mutant virus was
defective in propagation but does not explain the mechanisms that
render the mutant defective in viral maturation. Experiments are un-
derway to investigate why the mutant virus cannot continue its repli-
cation cycle. In conclusion, our experiments suggest that agnoprotein
may form dimers/oligomers in vivo and such structures may play criti-
cal roles for its function during the replication cycle of JCV.
Materials and methods
Cell lines
SVG-A is a subclonal population of a human glial cell line which
was established by transformation of human fetal glial cell line with
an origin-defective SV40 mutant and has been described previously
(Major et al., 1985). These cells do not express either SV40 viral cap-
sid proteins (VPs) or agnoprotein. Cells were grown in Dulbecco's
Modiﬁed Eagle's Medium (DMEM) supplemented with 10% heat-
inactivated fetal bovine serum (FBS) and antibiotics (penicillin/strep-
tomycin, 100 μg/mL). They were maintained at 37 °C in a humidiﬁed
atmosphere with 7% CO2.
Plasmid constructs
Full length (FL) JCV agnoprotein open reading frame with three
stop codons at the end of the gene was directionally subcloned into
Nco I/Eco RI sites of pMAL-c5x bacterial expression vector to produce
MBP-Agno fusion protein by PCR-based cloning. Bluescript KS-JCV-
Mad-1 WT plasmid was used as a template for PCR ampliﬁcation by
using the following primers: 5′ primer (5′-CCT CTA TCG CAG CCC
ATC CC ATG GGC GTT CTT CGC CAG CTG TCA CGT AAG 3′); 3′ primer
(5′-CCT CTA TCG CAG CCC ATC GAA TTC CTA TTA TTA TGT AGC TTT
TGG TTC AGG CAA AGC ACT-3). PCR product was ethanol-
precipitated, digested with Nco I and Eco RI restriction enzymes
(underlined sequences indicate the restriction sites for Nco I and
Eco RI respectively), gel puriﬁed and ligated into pMAL-c5x bacterial
expression vector and the resulting plasmid was designated as pMAL-
c5x JCV-Agno-FL. The following fragments of agnoprotein, encom-
passing amino acids, 1–16, 1–42, 17–71 and 43–71, were also cloned
into pMAL-c5x vector at Nco I and Eco RI sites by PCR-based cloning
as described for FL agnoprotein. They were designated as pMAL-c5x
JCV-Agno (1–16), pMAL-c5x JCV-Agno (1–42), pMAL-c5x JCV-Agno
(17–71) and pMAL-c5x JCV-Agno (43–71). These truncation mutants
of agnoprotein also contained a triple stop codon at the end of the
truncated gene. Full length of BKV and SV40 agnoprotein coding se-
quences was also cloned into pMAL-c5x vector by PCR-based cloning
at Nco I and Eco RI sites; and named pMAL-c5x-BKV Agno-FL and
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codon at the end of the gene was also directionally subcloned into
pGEX 1λT at Bam HI/Eco RI sites by PCR-based cloning as described
above to produce the GST-Agno fusion protein and designated as
pGEX 1λT-JCV Agno FL. Agnoprotein genome was PCR-ampliﬁed
from Bluescript KS-JCV-Mad-1 WT plasmid, using the following
primers: 5′ primer (5′-CCT CTA TCG CAG CCC GGA TTC ATG GGC
GTT CTT CGC CAG CTG TCA CGT AAG 3′); 3′ primer (5′-CCT CTA TCG
CAG CCC ATC GAA TTC CTA TTA TTA TGT AGC TTT TGG TTC AGG
CAA AGC ACT-3). Amino acids 17 to 42 were deleted from the virus
background by deletion mutagenesis using appropriate primers and
this plasmid was designated as Bluescript KS-JCV Mad-1 Agno
(Δ17–42). The integrity of the agnoprotein genome in all constructs
was veriﬁed by DNA sequencing.
Expression and afﬁnity puriﬁcation of Agno-fusion proteins
For the expression of the different MBP-Agnoprotein fusions,
pMAL-c5x-JCV-Agno-FL and pMAL-c5x vector containing the deletion
mutants of agnoprotein were transformed into E. coli DH5α cells. Bac-
terial cells were grown in 0.5–1 L LB media supplemented with ampi-
cillin (100 μg/mL) and glucose (2 g/L) at 37 °C until OD595=0.4.
Protein production was induced by the addition of and 0.3 mM IPTG
and the incubation temperature was lowered to 28 °C andmaintained
at that temperature for 2 h. Bacterial cells were harvested by centrifu-
gation (8000 rpm, Sorval-SLA-3000 rotor) and the resulting pellet
from the various MBP-Agno fusions were each resuspended in
20 mM Tris–HCl pH 7.4 containing 200 mM NaCl and 1 mM EDTA
[Amylose fast ﬂow (FF) column buffer]. The cell suspension was
then incubated on ice for 30 min in the presence of lysozyme and pro-
tease inhibitor cocktail, after which the cells were lysed by sonication.
Clear lysates were obtained after a high speed centrifugation at
15,000 rpm (Thermo Scientiﬁc, F21-8x50y rotor). The lysates were
then incubated with 125 μL of amylose FF resin (New England Bio-
labs) overnight at 4 °C to ensure efﬁcient binding of the proteins to
the resin beads. After incubation, the protein bound amylose resins
for each MBP-Agnoprotein fusion (FL and mutants) were washed
with ﬁve column volumes of amylose column binding buffer
(20 mM Tris pH 7.4, 200 mM NaCl, 1 mM EDTA). Target proteins
were either stored on beads at 4 °C or eluted with 10 mM maltose
prepared in the same buffer and stored at −30 °C until use.
The expression and protein extraction of the pGEX 1λT JCV-Agno
(GST-Agno FL) was carried out following a similar procedure as de-
scribed above for the MBP-Agno fusion proteins with a few modiﬁca-
tions. Protein expression was induced by the addition of 0.3 mM IPTG.
The bacterial pellet resulting from the cell growth was resuspended in
40 mL PENT buffer (20 mM Tris HCl pH 8.0, 100 mM NaCl, 1 mM
EDTA, 0.5% NP-40 and 1% N-L-Sarcosyl), and sonicated followed by
a high speed centrifugation at 15,000 rpm (Thermo Scientiﬁc,
F21-8x50y rotor). GST-Agno FL lysate was incubated with 150 μL
bed volume of GSH-Sepharose resin (GE HealthCare) overnight at
4 °C. GST-Agno beads were washed three times with PENT buffer
and resuspended in 1×PBS and were either kept in bound form at
4 °C or eluted from the GSH-Sepharose 4B beads using 20 mM gluta-
thione in 50 mM Tris–HCl buffer, pH 8.0. The eluted GST-Agnoprotein
was stored at−70 °C until use. The partner afﬁnity tags MBP and GST
were also each expressed and puriﬁed as a single protein following
the methods used for MBP-Agno and GST-Agno fusion proteins,
respectively.
Western blotting
For detection of agnoprotein in fusion protein complex, one micro-
gram of MBP alone and MBP-Agnoproteins (FL and mutants of agno-
protein) was analyzed on a 10% SDS-polyacrylamide gel after treating
the samples with 1×SDS loading dye containing β-mercaptoethanoland heating them at 95 °C for various amounts of time as indicated in
the respective ﬁgure legends. Proteins were transferred to a nitrocellu-
lose membrane for 3 h and detected with anti-agno polyclonal anti-
body and the detection was performed using ECL system following
the manufacturer's guidelines (Amersham, UK). For detection of agno-
protein in extracts prepared from the transfected/infected cells, 40 μg
of whole cell extracts prepared from SVG-A cells either untransfected
or transfected with Bluescript KS-JCV-Mad-1 WT plasmid (Sariyer
et al., 2006) was treated with SDS sample buffer and heated at 95 °C
for 5 min. In addition, 100 μg whole cell extract was immunoprecipi-
tated (IP) with either normal rabbit serum (5 μL) or with a polyclonal
anti-agno antibody (Del Valle et al., 2002; Safak et al., 2002) (5 μL),
treated in 1×SDS loading dye and heated at 95 °C for 5 min. Both
immunoprecipitated and normal protein samples were then separated
on a 15% SDS-polyacrylamide gel and transferred onto nitrocellulose
ﬁlter (Bio-Rad) for 10 min at 250 mA current. The blotted membranes
were probed with a polyclonal anti-agnoprotein antibody as described
earlier (Safak et al., 2002; Sariyer et al., 2006). The detection was per-
formed using ECL system following the manufacturer's guidelines
(Amersham, UK). For detection of VP1 in nuclear extracts prepared
from the transfected/infected cells, 40 μg of protein was separated on
a 10% SDS-polyacrylamide gel, transferred onto cellulose membrane
for 3 h at 250 mA and probed with anti-VP1 monoclonal antibody
(PAB597) using ECL detection kit.
Factor Xa cleavage
Puriﬁed MBP-Agno was dialyzed against the reaction buffer
(20 mM Tris–HCl pH 8.0, 100 mM NaCl) and incubated with Factor
Xa (NEB) in the presence of 2 mM CaCl2 for 3 h at room temperature
(RT). The samples were then analyzed on a 10% SDS-polyacrylamide
gel. In addition, cleavage products were also analyzed by Western
blotting, for which samples were ﬁrst separated on a 15% SDS-
polyacrylamide gel, transferred onto nitrocellulose ﬁlter (Bio-Rad)
and probed with a polyclonal anti-agno antibody (Safak et al., 2002).
LC–MS analysis
LC–MS analysis was performed by Wistar Institute Proteomic Fa-
cility, Philadelphia, PA (see Supplement 1).
MALDI-TOF analysis
MALDI-TOF analysis of the MBP-Agnoprotein complexes was per-
formed by Wistar Institute Proteomic Facility, Philadelphia, PA (see
Supplement 2).
Mapping homodimer and oligomer formation domain of agnoprotein
Eluted MBP alone or MBP-Agno FL or MBP-Agno deletion mutants
(1–16, 1–41, 17–71 and 43–71) (5 μg each) were separated on a 10%
SDS-polyacrylamide gel and analyzed by coomassie staining to mon-
itor dimer/oligomer formation.
Treatment of MBP-Agno dimer and oligomers with strong denaturing
agents
The stability of dimer and oligomers of agnoprotein was tested by
employing a prolonged heat treatment at 95 °C for various amounts
of time as indicated in the respective ﬁgure legend. Ten micrograms
of MBP-Agno was mixed with 1×SDS sample buffer (ﬁnal volume)
and heated at 95 °C for 5, 10, 20, 30, 45 and 60 min. Five micrograms
of each sample was fractioned on an 8% SDS-polyacrylamide gel and
analyzed by coomassie blue staining. The protein bands were quanti-
ﬁed using NIH ImageJ software. A hundred nanograms of the sample
were analyzed by Western blotting using a polyclonal anti-agno
64 A.S. Saribas et al. / Virology 420 (2011) 51–65antibody (Safak et al., 2002). Similarly, 5 μg of MBP-Agnoprotein was
subjected to treatment with an increasing concentration of SDS (1, 2,
5, 10, 15 and 20%) for 30 min at room temperature. 1×SDS sample
buffer was added to the samples and samples were then heated at
95 °C for 5 min, separated on a 10% SDS-polyacrylamide gel and ana-
lyzed by coomassie blue staining. The protein bands were then quan-
tiﬁed using NIH ImageJ software. The stability of agnoprotein dimers
and oligomers was also tested by treating the samples with high con-
centration of urea. Five micrograms of MBP-Agno was treated with
8 M urea (ﬁnal concentration) at room temperature for different pe-
riods of time as indicated in the respective ﬁgure, followed by addi-
tion of SDS sample loading dye and heating at 95 °C for 5 min. The
samples were then separated on an 8% SDS-polyacrylamide gel and
analyzed by coomassie blue staining.
Transfection/infection
SVG-A cells were transfected with either Bluescript KS-JCV Mad-1
WT or Bluescript KS-JCV Mad-1 Agno (Δ17–42) plasmids
(8 μg/2×106 cells/75 cm2 ﬂask) using lipofectin 2000 reagent (Sariyer
et al., 2006). Complete genome of JCV was liberated from Bluescript KS
vector by Bam HI digestion and used in transfections. Whole cell and
nuclear extracts were prepared at indicated time points from infected
and uninfected cells as described previously (Akan et al., 2006; Sariyer
et al., 2006) and analyzed by Western blotting using anti-VP1 antibody
(pAB597).
Anion exchange chromatography
MBP-Agno was puriﬁed in large scale using 10 mL amylose FF col-
umns, as described above, and pooled fractions of MBP-Agno fusion
protein (~17 mg) eluted from the amylose resin were ﬁrst exchanged
against 25 mM Tris–HCl, pH 7.5, 50 mM NaCl and 1 mM EDTA
(Buffer A) using a PD10 gel ﬁltration column. This sample was then
loaded onto a 25 mL Q Sepharose anion exchange column (Amer-
sham Biosciences) preequilibrated with the same buffer. The column
was initially washed with 50 mL of Buffer A to remove unbound pro-
teins. The fusion protein was eluted using a linear gradient of 50–
1000 mM NaCl collecting 8 mL fractions. Aliquots (15 μL) of each
fraction from the anion-exchange step were analyzed on a 4–12%
SDS-polyacrylamide gel, followed by coomassie staining.
Gel ﬁltration chromatography
In an attempt to separate the different oligomeric forms of the fu-
sion protein, the Q Sepharose fractions containing the MBP-Agno di-
mers and monomers were pooled and concentrated using an
Amicon spin concentrator (10 kDa MW cut off) to obtain a total of
12 mg of protein. Gel ﬁltration chromatography was carried out
using a high resolution resin (Sephacryl HR200, exclusion range of
5 to 250 kDa) equilibrated with 25 mM Tris–HCl, 50 mM NaCl and
1 mM EDTA. Fractions were collected using 1.5× column volume buff-
er (~180 mL) to elute the proteins. Fractions were analyzed on a
4–12% SDS-polyacrylamide gel followed by coomassie staining.
Replication assay
Replication assays were carried out as previously described (Safak
et al., 2001). Brieﬂy, SVG-A cells (2×106 cells) grown in 75 cm2 ﬂasks
were transfected either with JCV Mad-1 WT or JCV Mad-1 Agno
(Δ17–42) viral genomes (8 μg/2×106 cells/75 cm2 ﬂask) by
lipofectin-2000 transfection method, as described under the transfec-
tion section. At indicated time points posttransfection, low-
molecular-weight DNA containing both input and replicated viral
DNA was isolated by the Hirt method (Hirt, 1967), digested withBam HI and Dpn I enzymes, resolved on a 1% agarose gel and analyzed
by Southern blotting.
Viral particle release assay
JCV Mad-1 WT genome or JCV Mad-1 Agno (Δ17–42) genomes
were separately transfected into SVG-A cells (8 μg DNA/2×106
cells/75 cm2 ﬂask), as described under transfection/infection section.
Supernatants from infected cells were collected at indicated time
points, centrifuged at 16,000 ×g to clear cell debris and were sub-
jected to immunoprecipitation using an anti-VP1 monoclonal anti-
body (PAB597) (4 μL). Half of the samples were analyzed by
Western blotting using anti-VP1 antibody (PAB597), and the other
half was analyzed by Southern blotting for detection of the encapsi-
dated viral DNA. The viral DNA from capsids was puriﬁed employing
Qiagen spin columns (Ziegler et al., 2004), digested with Bam HI and
Dpn I enzymes, resolved on a 1% agarose gel and analyzed by South-
ern blotting using probes prepared from whole Mad-1 genome.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.virol.2011.08.015.
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